{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:53:37Z","timestamp":1761058417316},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1093\/jac\/dkl047","type":"journal-article","created":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T02:37:38Z","timestamp":1141180658000},"page":"931-936","source":"Crossref","is-referenced-by-count":32,"title":["Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae"],"prefix":"10.1093","volume":"57","author":[{"given":"Sandra","family":"Ribes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Taberner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Cabellos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fe","family":"Tubau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefina","family":"Li\u00f1ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Fern\u00e1ndez","family":"Viladrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Gudiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,2,28]]},"reference":[{"key":"key\n\t\t\t\t20171010182706_B1","doi-asserted-by":"crossref","unstructured":"Friedland IR, McCracken GH, Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med1994; 331: 377\u201382.","DOI":"10.1056\/NEJM199408113310607"},{"key":"key\n\t\t\t\t20171010182706_B2","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics. Therapy for children with invasive pneumococcal infections. Pediatrics1997; 99: 289\u20139.","DOI":"10.1542\/peds.99.2.289"},{"key":"key\n\t\t\t\t20171010182706_B3","doi-asserted-by":"crossref","unstructured":"Tunkel AR, Hartman BJ, Kaplan SL et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis2004; 39: 1267\u201384.","DOI":"10.1086\/425368"},{"key":"key\n\t\t\t\t20171010182706_B4","doi-asserted-by":"crossref","unstructured":"Nau R, Kaye K, Sachdeva M et al. Rifampin for therapy of experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother1994; 38: 1186\u20139.","DOI":"10.1128\/AAC.38.5.1186"},{"key":"key\n\t\t\t\t20171010182706_B5","doi-asserted-by":"crossref","unstructured":"Perrig M, Acosta F, Cottagnoud M et al. Efficacy of gatifloxacin alone and combined with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro. J Antimicrob Chemother2001; 47: 701\u20134.","DOI":"10.1093\/jac\/47.5.701"},{"key":"key\n\t\t\t\t20171010182706_B6","doi-asserted-by":"crossref","unstructured":"Martinez-Lacasa J, Cabellos C, Martos A et al. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. J Antimicrob Chemother2002; 49: 507\u201313.","DOI":"10.1093\/jac\/49.3.507"},{"key":"key\n\t\t\t\t20171010182706_B7","doi-asserted-by":"crossref","unstructured":"Domenech A, Cabellos C, Ribes S et al. Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and -resistant pneumococcal meningitis. Microb Drug Resist2003; 9 Suppl 1: S53\u20139.","DOI":"10.1089\/107662903322541900"},{"key":"key\n\t\t\t\t20171010182706_B8","doi-asserted-by":"crossref","unstructured":"Hendlin D, Stapley EO, Jackson M et al. Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science1969; 166: 122\u20133.","DOI":"10.1126\/science.166.3901.122"},{"key":"key\n\t\t\t\t20171010182706_B9","doi-asserted-by":"crossref","unstructured":"Sicilia T, Estevez E, Rodriguez A. Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis. Chemotherapy1981; 27: 405\u201313.","DOI":"10.1159\/000238009"},{"key":"key\n\t\t\t\t20171010182706_B10","doi-asserted-by":"crossref","unstructured":"Banon Arias R, Garcia Lopez M, Pinedo Sanchez A. Time-kill evaluation of antimicrobial regimens against clinical isolates of penicillin-resistant Streptococcus pneumoniae. J Chemother2001; 13: 535\u201340.","DOI":"10.1179\/joc.2001.13.5.535"},{"key":"key\n\t\t\t\t20171010182706_B11","doi-asserted-by":"crossref","unstructured":"Pfausler B, Spiss H, Dittrich P et al. Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis. J Antimicrob Chemother2004; 53: 848\u201352.","DOI":"10.1093\/jac\/dkh158"},{"key":"key\n\t\t\t\t20171010182706_B12","unstructured":"Stahl JP, Croize J, Bru JP et al. Diffusion of fosfomycin into the cerebrospinal fluid in purulent meningitis. Presse Med1984; 13: 2693\u20135."},{"key":"key\n\t\t\t\t20171010182706_B13","unstructured":"Guggenbichler JP, Menardi G, Hager J. Antimicrobial therapy of bacterial meningitis in premature- and newborn infants and shunt infections. In: Guggenbichler JP, ed. New Aspects for Treatment with Fosfomycin, New York: Springer, 1987: 41\u201357."},{"key":"key\n\t\t\t\t20171010182706_B14","doi-asserted-by":"crossref","unstructured":"Nau R, Zysk G, Reinert RR et al. Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis. J Antimicrob Chemother1995; 36: 997\u20131004.","DOI":"10.1093\/jac\/36.6.997"},{"key":"key\n\t\t\t\t20171010182706_B15","unstructured":"Sloas MM, Barrett FF, Chesney PJ et al. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J1992; 11: 662\u20136."},{"key":"key\n\t\t\t\t20171010182706_B16","doi-asserted-by":"crossref","unstructured":"McGee L, McDougal L, Zhou J et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol2001; 39: 2565\u201371.","DOI":"10.1128\/JCM.39.7.2565-2571.2001"},{"key":"key\n\t\t\t\t20171010182706_B17","doi-asserted-by":"crossref","unstructured":"Andrews JM, Baquero F, Beltran JM et al. International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother1983; 12: 357\u201361.","DOI":"10.1093\/jac\/12.4.357"},{"key":"key\n\t\t\t\t20171010182706_B18","unstructured":"National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically\u2014Fifth Edition: Approved Standard M7-A5. NCCLS, Villanova, PA, USA, 2000."},{"key":"key\n\t\t\t\t20171010182706_B19","unstructured":"Eliopoulos GM, Moellering RC, Jr. Antimicrobial combinations. In: Lorian V, ed. Antibiotics in Laboratory Medicine, 4th edn. Baltimore: Williams & Wilkins Co., 1996; 330\u20136."},{"key":"key\n\t\t\t\t20171010182706_B20","doi-asserted-by":"crossref","unstructured":"Dacey RG, Sande MA. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother1974; 6: 437\u201341.","DOI":"10.1128\/AAC.6.4.437"},{"key":"key\n\t\t\t\t20171010182706_B21","doi-asserted-by":"crossref","unstructured":"Ribes S, Domenech A, Cabellos C et al. Experimental meningitis due to a high-level cephalosporin-resistant strain of Streptococcus pneumoniae serotype 23F. Enferm Infecc Microbiol Clin2003; 21: 329\u201333.","DOI":"10.1157\/13050522"},{"key":"key\n\t\t\t\t20171010182706_B22","doi-asserted-by":"crossref","unstructured":"Cabellos C, Martinez-Lacasa J, Tubau F et al. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporin-resistant pneumococcal meningitis. J Antimicrob Chemother2000; 45: 315\u201320.","DOI":"10.1093\/jac\/45.3.315"},{"key":"key\n\t\t\t\t20171010182706_B23","doi-asserted-by":"crossref","unstructured":"Sicilia T, Fadon A, Rodriguez A et al. Fosfomycin in pneumococcal meningitis. Chemotherapy1977; 23 Suppl 1: 429\u201340.","DOI":"10.1159\/000222087"},{"key":"key\n\t\t\t\t20171010182706_B24","doi-asserted-by":"crossref","unstructured":"Kuhnen E, Pfeifer G, Frenkel C. Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges. Infection1987; 15: 422\u20134.","DOI":"10.1007\/BF01647220"},{"key":"key\n\t\t\t\t20171010182706_B25","doi-asserted-by":"crossref","unstructured":"Doit CP, Bonacorsi SP, Fremaux AJ et al. In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis. Antimicrob Agents Chemother1994; 38: 2655\u20139.","DOI":"10.1128\/AAC.38.11.2655"},{"key":"key\n\t\t\t\t20171010182706_B26","doi-asserted-by":"crossref","unstructured":"Ribes S, Taberner F, Domenech A et al. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916. J Antimicrob Chemother2005; 56: 979\u201382.","DOI":"10.1093\/jac\/dki323"},{"key":"key\n\t\t\t\t20171010182706_B27","doi-asserted-by":"crossref","unstructured":"Barakett V, Lesage D, Delisle F et al. Synergy of cefotaxime and fosfomycin against penicillin-resistant pneumococci. J Antimicrob Chemother1993; 31: 105\u20139.","DOI":"10.1093\/jac\/31.1.105"},{"key":"key\n\t\t\t\t20171010182706_B28","doi-asserted-by":"crossref","unstructured":"Cassinat B, Nicolas MH. Comparison of antibiotic combinations against penicillin-resistant pneumococci. J Antimicrob Chemother1994; 34: 785\u201390.","DOI":"10.1093\/jac\/34.5.785"},{"key":"key\n\t\t\t\t20171010182706_B29","doi-asserted-by":"crossref","unstructured":"Chavanet P, Beloeil H, Pechinot A et al. In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother1995; 39: 1736\u201343.","DOI":"10.1128\/AAC.39.8.1736"},{"key":"key\n\t\t\t\t20171010182706_B30","doi-asserted-by":"crossref","unstructured":"Tubau F, Cabellos C, Li\u00f1ares J. Lack of correlation between in vitro and in vivo studies of combinations of rifampin plus vancomycin or beta-lactam antibiotics against Streptococcus pneumoniae. Antimicrob Agents Chemother1996; 40: 1573\u20134.","DOI":"10.1128\/AAC.40.6.1573"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/57\/5\/931\/2297123\/dkl047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T03:43:17Z","timestamp":1555472597000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/57\/5\/931\/764421\/Evaluation-of-fosfomycin-alone-and-in-combination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,28]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,2,28]]},"published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkl047","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,5]]},"published":{"date-parts":[[2006,2,28]]}}}